Rebirth of the Strongest Tycoon

Among the three groups, Xia Yu's group was responsible for conquering the Coleil Perkins Company, which had the strongest relationship with Professor Herb Boyle.

Although Coller Perkins invested in Genentech three times and seemed to have always supported Professor Herb Boyle, Xia Yu didn't care.

Weakness is the Achilles heel of Coller Perkins. A venture capital firm with such strength generally invests in Angel rounds or A rounds, and it is already the limit to be able to follow up with B rounds.

Genentech was pushed to go public, and it is not in the C round of financing. It is possible that they are behind the scenes.

For example, the valuation of Genentech at this time exceeds 100 million. If the C round of financing is opened, 10% of the equity needs to be at least 10 million US dollars, or even more.

With the strength of Coller Perkins, it is difficult to keep up. After all, their company's workable capital does not exceed 50 million US dollars, and it is impossible to invest in only one project of Genentech, so the company's liquidity will never be many.

The valuation of Genentech is high enough. It is the best way to launch it to go public and let public capital take the risk. Coller Perkins can also make a profit and use the huge profits earned to invest in new seedlings Businesses grow in this cycle.

Because they had made an appointment in advance, Xia Yu and others were led by the receptionist and met Harry Morrison, the CEO of Claire Perkins, and two other executives.

Seeing that Xia Yu's team of five people was centered on a young yellow race, Harry Morrison's eyes narrowed, and several thoughts flashed in his heart.

As for Polaris Capital, Harry Morrison had never heard of it before, that is, when he was booked yesterday, he specifically inquired about it, and received little news, only that it was a newly established company.

But he did not doubt the strength of Polaris Capital, because according to his investigation, Polaris Capital bought a 30-story office building in downtown San Francisco.

Anyway, with the strength of their Coleiller Perkins company, there is absolutely no spare money to buy office buildings!

Therefore, he has a cautious and even vigilant attitude towards Polaris Capital, whose purpose is unknown.

It is best not to offend a company with such a mysterious background!

Harry Morrison didn't show his true attitude. He warmly greeted Xia Yu and others to take their seats. After his subordinates poured tea and coffee for everyone, he drank coffee and chatted with Xia Yu.

"Mr. Xia, it's an honor to meet you, and you are welcome!"

"Thank you Mr Morrison for your hospitality!"

...

"Mr. Xia, what can I do for you when you come this time?" Harry Morrison asked after the greeting, looking closely at Xia Yu.

Xia Yu smiled slightly and said, "I'm here to disturb you this time, mainly because I want to do your company a favor. Of course, if I tell the truth, it's also beneficial to us. It's a win-win situation."

Harry Morrison nodded unequivocally, but he was even more vigilant in his heart. He didn't believe there was such a good thing, and he then asked, "I don't know what it is?"

Xia Yu smiled and said bluntly: "Actually, I want to acquire the equity of Genentech held by your company."

Harry Morrison's expression changed suddenly, and before he could speak, a middle-aged white man in his thirties said decisively: "Impossible, Genentech's equity is not for sale in our company!"

Seeing the person beside him say it, Harry Morrison's face softened a little, but his tone was equally cold, as if he didn't leave a trace of leeway, and refused: "I'm sorry, Mr. Xia, we can't meet your request!"

Xia Yu stopped the subordinate who wanted to speak, looked indifferent, smiled and looked at the person who spoke first, and asked, "Sir, can I be fortunate enough to know your name?"

Xia Yu's attitude was very friendly, so the middle-aged white man's face softened a little, and he spit out a few words: "Robert Swanson!"

Xia Yu suddenly understood that it was the one who discovered Genentech.

No wonder the reaction was so intense.

With his achievements in unearthing Genentech, it is normal to become a senior partner at Claire Perkins, no wonder he can accompany Harry Morrison.

Xia Yu said with a smile: "Mr. Swanson, and Mr. Morrison, in fact, there is no need for you to refuse so quickly, there is nothing in the world that cannot be sold, the key is whether the price can be satisfied, I have not yet bid, Why did you refuse so quickly?"

"Maybe my price will satisfy you?"

Harry Morrison and Robert Swanson looked at each other, both seeing surprise in the other's eyes.

After Robert Swanson made eye contact with Harry Morrison, he said with a cold expression: "Mr. Xia, Genentech is now in the process of going public. Now the valuation is several times higher, why should we pick the fruit in advance?”

Xia Yu shook his head and retorted: "It's hard to say whether it is several times higher, because so far, Genentech has not made a profit, and no one knows how the capital market will choose, maybe it will fall below the issue price?"

Robert Swanson is not a fuel-efficient lamp either. He directly seized Xia Yu's painful foot and strongly retorted: "It will never fall below the issue price! Maybe I was not sure how the capital market would choose before, but today you are here, Instead, our confidence has been strengthened, and I believe that Genentech will definitely be able to successfully go public, and the stock price will be significantly higher than the opening price!"

Well, this rhetoric of Xia Yu was directly blocked by Robert Swanson.

But Xia Yu had prepared well before he came, and he had already thought of a lot of reasons for the negotiation.

He didn't admit Robert Swanson's statement, he ignored it, opened another battle and said: "Mr. Swanson, if it takes half a year, Genentech can go public, but your original equity will be locked for one year before it can be unlocked. , which means that for at least one and a half years, your funds will be locked, and even if Genentech's stock price is high, you will not be able to cash out."

"With the current speed of technological development, there will be countless companies with strong potential in this year and a half. Are you willing to miss out on financial reasons?"

Weak strength is the Achilles heel. If Coleiller Perkins has strong capital, Xia Yu's reason is simply untenable.

But saying it now makes Harry Morrison and Robert Swanson and others look ugly.

At this time, another middle-aged man, Colin Hicks, who had been sitting in silence, defended aloud: "Mr. Xia, you don't need to worry about this, we can afford it in half a year, and Genentech goes public. Now, even if our original shares are locked, we can also pledge our equity to find bank loans.”

"And I believe that as long as Genentech goes public, there will be a steady stream of investors waving US dollars to invest in us."

Xia Yu said with a smile: "It's hard to say whether there will be investors coming to the door. After all, it hasn't happened yet. Let me just say one thing. If you want to pledge the loan with Genentech's equity, the precondition is that Genentech is successfully listed."

"And then, you are also very aware of the conservative nature of the banks. They like the stocks of companies listed on the New York Stock Exchange. For the stocks of Nasdaq, they do not approve, otherwise, the capital market of venture capital will not appear."

"Even if you find a bank willing to pledge loans, the loan ratio is four or five layers. After all, for banks, the Nasdaq stocks with negative earnings and high stock prices are too risky."

"With so many risks, you still need to pay high interest to the bank. What will happen if Genentech's stock price plummets, or you don't find new potential companies?"

Xia Yu's statement made the three of them speechless, not knowing how to refute it.

ps: Book subscription for tickets!

https://

Please remember this book's first domain name: . Apex Novel Mobile Version Reading URL: